% Expired Patents = 40.0

EPO Patents = 5

Forward Citations = 71

Loading Chart...

7 inventors (with patents filed for the assignee):

Pierre Roy (3 out of 53 patents)

Michel Paques (3 out of 4 patents)

Caroline Leriche (2 out of 10 patents)

4. David Middlemiss (2 out of 21 patents)

5. John Thomas Feutrill (1 out of 12 patents)

6. Eric Auclair (1 out of 1 patent)

7. Jacques Le Roux (1 out of 1 patent)

8. Pierre Belichard (1 patent)

9. Didier Pruneau (0 patent)

10. José Sahel (0 patent)

11. Sebastien Bonnel (0 patent)

5 patents: Sort by Forward Citations

1. 9308125 - Apparatus for intra-ocular injection (2016-04-12),

2. 9249085 - Aniline derivatives, their preparation and their therapeutic application (2016-02-02),

3. 8808242 - Apparatus for injection into an eye (2014-08-19),

4. 8460242 - Apparatus for intra-ocular injection (2013-06-11),

5. 8389530 - Substituted quinazoline compounds (2013-03-05),

Company Overview

Fovea Pharmaceuticals is a leading biopharmaceutical company dedicated to developing innovative treatments for sight-threatening diseases. With a focus on retinal disorders, Fovea's cutting-edge research and development efforts aim to improve the quality of life for patients worldwide. Through strategic partnerships and collaborations with top scientists and healthcare professionals, Fovea is committed to delivering breakthrough therapies that address unmet medical needs in the field of ophthalmology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#568 in Paris

#2,863 in France

Paris, France

Fovea Pharmaceuticals

Forward Citations = 71

7 inventors:

Pierre Roy (3 out of 53 patents)

Michel Paques (3 out of 4 patents)

Caroline Leriche (2 out of 10 patents)

4. David Middlemiss (2 out of 21 patents)

5. John Thomas Feutrill (1 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fovea Pharmaceuticals. Retrieved from https://idiyas.com/company/fovea-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]